What to do about the problem of non-FDA approved compounded bioidentical hormones

Article Type
Audio
Changed
Tue, 01/05/2021 - 12:53
Display Headline
What to do about the problem of non-FDA approved compounded bioidentical hormones
Author(s)
Cynthia Stuenkel, MD

 

Click here to download

Author and Disclosure Information

Dr. Stuenkel is Clinical Professor, Department of Medicine, University of California, La Jolla.

Dr. Stuenkel reports that she has no financial relationships relevant to this audiocast.

Issue
OBG Management - 29(10)
Publications
MDedge ObGyn
OBG Management
Sections
Expert Commentary
Author(s)
Cynthia Stuenkel, MD
Author(s)
Cynthia Stuenkel, MD
Author and Disclosure Information

Dr. Stuenkel is Clinical Professor, Department of Medicine, University of California, La Jolla.

Dr. Stuenkel reports that she has no financial relationships relevant to this audiocast.

Author and Disclosure Information

Dr. Stuenkel is Clinical Professor, Department of Medicine, University of California, La Jolla.

Dr. Stuenkel reports that she has no financial relationships relevant to this audiocast.

 

Click here to download

 

Click here to download

Issue
OBG Management - 29(10)
Issue
OBG Management - 29(10)
Publications
MDedge ObGyn
OBG Management
Publications
MDedge ObGyn
OBG Management
Article Type
Audio
Display Headline
What to do about the problem of non-FDA approved compounded bioidentical hormones
Display Headline
What to do about the problem of non-FDA approved compounded bioidentical hormones
Sections
Expert Commentary
Disallow All Ads
Content Gating
No Gating (article Unlocked/Free)
Alternative CME
Disqus Comments
Default
Use ProPublica
Hide sidebar & use full width
render the right sidebar.
Conference Recap Checkbox
Not Conference Recap
Clinical Edge
Display the Slideshow in this Article
Medscape Article
Teaser Media
Subscribe to Cynthia Stuenkel, MD